Panuri Test for Suspected Pancreatic Cancer
Part of Cancer clinical trials.
This study tests a new diagnostic tool called Panuri to help detect pancreatic cancer in adults who have symptoms suggesting the disease. The test may help doctors identify pancreatic cancer earlier and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have symptoms that make your doctor suspect pancreatic cancer (such as jaundice, abdominal pain, weight loss, or digestive problems)
- Not have a prior pancreatic cancer diagnosis or pancreatic surgery
- Not have had cancer in the past 5 years or recent cancer treatment
- Not have certain kidney or liver diseases that could affect test results
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses imaging tests like CT scans or endoscopic ultrasound to look for early signs of pancreatic cancer in people who have recently developed diabetes. It aims to find cancer early, when it might be easier to treat.
This study looks at tissue samples from people having surgery for a suspected pancreatic growth to find markers that might help diagnose pancreatic cancer earlier. By studying the removed tissue, researchers hope to learn more about the earliest changes that lead to cancer.
This study is a registry that follows people who have had the PancreasSure blood test ordered by their doctor. It aims to see how well this test helps detect early-stage pancreatic cancer in people who are at higher risk, and the information gathered may help improve early detection for others.
This study is looking at healthy adults who have no symptoms or risk factors for pancreatic cancer to test a new imaging method that may help find early signs of the disease. If you join, you will have an endoscopic ultrasound (a thin tube with a camera passed to your stomach) to check your pancreas.
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.